HB0028

· Shanghai Huaota Biopharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HB0028, covering 2024-01-25 to 2024-01-25. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating the Safety and Efficacy of HB0028 in Subjects With Advanced Solid Tumors [Phase 1, Phase 2]